Kibow Biotech to exhibit Its "Enteric Dialysis" Technology at ASN 2018

World |  News | 0 Comment | 24 Oct, 2018

Kibow Biotech is proud to announce its 21st year of operations as a pioneer with the use of Pro/Prebiotics in people wit...Read more

Epilepsy Society, UCL, Congenica unite to identify cause of epileptic death

World |  News | 0 Comment | 23 Oct, 2018

Congenica, the global diagnostic decision support platform provider, announced a key partnership with the UK’s&nbs...Read more

Stream Bio expands its CPN products distribution network across Europe

World |  News | 0 Comment | 23 Oct, 2018

Stream Bio Ltd, a company that develops and manufactures a range of revolutionary bioimaging molecular probes, is expand...Read more

AstraZeneca's Lynparza shown to cut cancer progression by 70%

World |  News | 0 Comment | 22 Oct, 2018

AstraZeneca and Merck  have announced detailed results from the Phase III SOLO-1 trial testing Lynparza (...Read more

FDA approves Regeneron, Sanofi's Dupixent for asthma treatment

World |  News | 0 Comment | 22 Oct, 2018

Singapore - The FDA approves Regeneron Pharmaceuticals and development partner Sanofi's DUPIXENT (dupilumab) a...Read more

Roche's Tecentriq extends progression-free survival in TNBC

World |  News | 0 Comment | 22 Oct, 2018

Singapore - Results from a Phase 3 clinical trial, IMpassion130, evaluating Roche unit Genentech's TECENTRIQ (...Read more

Luminex to acquire MilliporeSigma’s flow cytometry portfolio

World |  News | 0 Comment | 21 Oct, 2018

Luminex has signed a definitive agreement to buy MilliporeSigma’s flow cytometry portfolio for $75 million. This ...Read more

NIA releases National Recruitment Strategy to spur dementia based research

World |  News | 0 Comment | 20 Oct, 2018

Recruitment and retention in clinical studies for Alzheimer’s disease remains one of the biggest hurdles in the pa...Read more

apceth Biopharma announces positive results for apceth-201 in mouse models

World |  News | 0 Comment | 19 Oct, 2018

apceth Biopharma GmbH, a company with the mission of improving patients’ lives with next generation cell therapies...Read more

Emergent BioSolutions acquires Adapt Pharma

World |  News | 0 Comment | 19 Oct, 2018

Adapt Pharma, maker of the naloxone nasal spray Narcan used for the emergency treatment of known or suspected opioid ove...Read more

RepliCel Life Sciences appoints new CFO

World |  News | 0 Comment | 19 Oct, 2018

RepliCel Life Sciences Inc., a company developing next-generation technologies in aesthetics and orthopedics, announces ...Read more

Acticor Biotech raises €15.3M in Series B Financing

World |  News | 0 Comment | 19 Oct, 2018

Acticor Biotech, a clinical stage biotechnology company involved in the acute phase of thrombotic diseases, including st...Read more

Arcis Biotech, Teleflex sign a license agreement

World |  News | 0 Comment | 19 Oct, 2018

Arcis Biotechnology, the nucleic acid sample preparation solution provider has announced that it has signed a technology...Read more

Beckman Coulter Life Sciences launches new research focused website

World |  News | 0 Comment | 19 Oct, 2018

For a quarter century, the Beckman Coulter name has been important to clinicians and researchers worldwide. For the latt...Read more

Co-Diagnostics receives CE mark for Zika Test

World |  News | 0 Comment | 19 Oct, 2018

US based Co-Diagnostics, Inc., a molecular diagnostics company with a unique, proprietary platform for the development o...Read more

Axsome receives FDA Orphan Drug designation for narcolepsy drug

World |  News | 0 Comment | 17 Oct, 2018

Singapore - Axsome Therapeutics, a clinical-stage biopharmaceutical company developing novel therapies for the mana...Read more

Merck appoints new Chief Information and Digital Officer

World |  News | 0 Comment | 17 Oct, 2018

Singapore - Merck, known as MSD outside the United States and Canada, announced the appointment of Jim Scholefield as ch...Read more

Medivir lowers research costs to focus on clinical development

World |  News | 0 Comment | 17 Oct, 2018

Singapore - Medivir AB announced plans to reduce activities not critical to its development pipeline of drug candidates ...Read more